These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1053 related articles for article (PubMed ID: 28009743)

  • 1. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
    Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation.
    Chok KSH; Chan ACY; Fung JYY; Dai WC; Cheung TT; Lo CM
    Hepatol Int; 2017 Nov; 11(6):517-522. PubMed ID: 28936686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS; Goja S; Yadav SK; Tamang TY; Rastogi A; Bhangui P; Thiagrajan S; Raut V; Babu RY; Saigal S; Saraf N; Choudhary NS; Vohara V
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Outcomes in Split Compared With Whole Liver Transplantation.
    Chul Yoon K; Song S; Jwa EK; Lee S; Man Kim J; Kim OK; Kyun Hong S; Yi NJ; Lee KW; Soo Kim M; Hwang S; Suh KS; Lee SK
    Liver Transpl; 2018 Oct; 24(10):1411-1424. PubMed ID: 29747216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC; Fung JY; Pang HH; Leung CK; Li HF; Sin SL; Ma KW; She BW; Dai JW; Chan AC; Cheung TT; Lo CM
    Hepatology; 2021 Jun; 73(6):2441-2454. PubMed ID: 33006772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.
    Jiang L; Yan L; Tan Y; Li B; Wen T; Yang J; Zhao J
    Surg Today; 2013 Sep; 43(9):1039-48. PubMed ID: 23467980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after live donor versus deceased donor liver transplantation: propensity score-matched study.
    Kaltenmeier C; Liu H; Zhang X; Ganoza A; Crane A; Powers C; Gunabushanam V; Behari J; Molinari M
    BJS Open; 2024 May; 8(3):. PubMed ID: 38837956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
    Goldberg DS; Ruebner RL; Abt PL
    Am J Transplant; 2015 Oct; 15(10):2732-8. PubMed ID: 25969133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T; Yoshizumi T; Sakata K; Uchiyama H; Harimoto N; Harada N; Itoh S; Nagatsu A; Soejima Y; Maehara Y
    Liver Transpl; 2016 Dec; 22(12):1666-1675. PubMed ID: 27540888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.